Skip to main content

Table 6 Comparative analysis on costs per QALY

From: Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

 

POLYMOD

Roxanne

CoRoVa

Health-care perspective

   

Afr

$ 265a

$ 188-367b

$ 233-440 b

Sear

$ 358a

$ 257-503b

$ 308-591 b

Amr

$ 307a

$ 200-652b

$ 336-862 b

Eur

€ 57,897

€ 50,999

€ 56,656

Societal perspective

   

Afr

$ 260a

$ 185-364 b

$ 231-438 b

Sear

$ 328a

$ 241-487 b

$ 293-577 b

Amr

$ 196a

$ 143-595 b

$ 282-809 b

Eur

€ 49,427

€ 40,041

€ 44,263

  1. a. based on future reduction of vaccine prices from $7.5 to $4; b. Range given for previous upper and lower vaccine prices